85.40 USD
+0.47 (+0.55%)
AT CLOSE (11:59 AM EDT)
Kymera Therapeutics, Inc. Common Stock (KYMR)
NASDAQ: KYMR • USD
85.35
-0.09 (-0.11%)
POST MARKET (AS OF 05:01 PM EDT)
Market: OPEN
Open?$82.78
High?$85.65
Low?$82.67
Prev. Close?$84.93
Volume?690.9K
Avg. Volume?779.4K
VWAP?$84.40
Rel. Volume?0.89x
Bid / Ask
Bid?$85.29 × 100
Ask?$85.98 × 100
Spread?$0.69
Midpoint?$85.64
Valuation & Ratios
Market Cap?6.9B
Shares Out?31.4M
Float?49.4M
Float %?68.7%
P/E Ratio?N/A
P/B Ratio?4.39
EPS?-$3.81
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?10.47Strong
Quick Ratio?10.47Strong
Cash Ratio?4.29Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?4.39FAIR▾
P/S?176.84HIGH▾
P/FCF?N/A▾
EV/EBITDA?-19.5CHEAP▾
EV/Sales?167.82HIGH▾
Returns & Efficiency
ROE?-19.7%WEAK▾
ROA?-17.9%WEAK▾
Cash Flow & Enterprise
FCF?$-234340000
Enterprise Value?$6.6B
Related Companies
Loading...
News
Profile
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
Employees
238
Market Cap
6.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-08-21
Address
500 NORTH BEACON STREET, 4TH FLOOR
WATERTOWN, MA 02472
Phone: 857-285-5314
WATERTOWN, MA 02472
Phone: 857-285-5314